Daxor to Present Blood Volume Analysis Platform at ASN Kidney Week 2026
Daxor Corporation (DXR) announced that it will exhibit its Blood Volume Analysis (BVA) platform at the American Society of Nephrology (ASN) Kidney Week 2026. The annual exposition takes place from October 21 to October 25, 2026, at the Colorado Convention Center in Denver. Shares of Daxor Corporation were trading at $10.30, down 1.02% on the day.
The company's FDA-cleared diagnostic system directly measures total blood, red blood cell, and plasma volume. In managing complex kidney conditions such as cardiorenal syndrome, acute kidney injury, and end-stage renal disease, standard clinical indicators like weight changes can be inaccurate. Precise measurement provides objective data to help clinicians make safer decisions regarding fluid management.
During the event, representatives from Daxor Corporation plan to provide live platform demonstrations, discuss clinical workflow integration, and review reimbursement pathways with nephrology professionals.
Key points
- Daxor Corporation will exhibit its BVA diagnostic technology at ASN Kidney Week 2026 in Denver, Colorado, from October 21 to October 25.
- The FDA-cleared platform directly measures total blood, red blood cell, and plasma volume to support fluid management in kidney care.
- Company representatives will offer live platform overviews, review clinical integration, and discuss reimbursement pathways during the event.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
When and where is Daxor presenting its blood volume technology?
Daxor Corporation will exhibit at ASN Kidney Week 2026 at the Colorado Convention Center in Denver, Colorado, from October 21 through October 25, 2026.
What is Daxor's Blood Volume Analysis technology?
It is an FDA-cleared diagnostic system that directly measures total blood, red blood cell, and plasma volume to help physicians precisely manage fluid balance in patients with kidney disease.